
Happy Mammoth Hormone Harmony
We’ve got some sad news: This supplement company’s health claims violate the law.
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)
We’ve got some sad news: This supplement company’s health claims violate the law.
Colin Campbell, GameDaily.biz
TINA.org finds several issues with marketing of purported tinnitus supplement.
Peter Adams, Marketing Dive
Universe of Play’s removal follows action led by TINA.org – and inaction from self-reg group.